Danish Trade Distributors Stock News

Novo Nordisk (CPSE:NOVO B) presented new POSEIDON study data on cardiovascular inflammation at a major scientific congress. The study found that many patients with atherosclerotic cardiovascular disease, chronic kidney disease, or heart failure have persistent cardiovascular inflammation despite guideline recommended care. These real world findings highlight a significant unmet medical need and may influence future approaches to cardiovascular risk reduction. Novo Nordisk, traded as...

H. Lundbeck (CPSE:HLUN B) is back on investors’ radar after South Korea’s Ministry of Food and Drug Safety granted marketing authorization for eptinezumab, its intravenous anti-CGRP preventive migraine treatment for adults. See our latest analysis for H. Lundbeck. The eptinezumab approval lands at a time when Lundbeck’s DKK42.84 share price has a 90 day share price return of 11.62%, while the 1 year total shareholder return of 21.57% points to momentum that has built over a longer period...

Royal Unibrew stock performance and recent valuation context Royal Unibrew (CPSE:RBREW) has caught investor attention after a period of weaker share performance, with the stock down about 36% over the past 3 months and roughly 27% year to date. See our latest analysis for Royal Unibrew. At a share price of DKK411.0, Royal Unibrew’s recent slide is clearer in context, with the 90 day share price return down 35.73% and the 1 year total shareholder return down 21.71%, pointing to fading momentum...

Amid a backdrop of rising hopes for geopolitical de-escalation and positive market momentum, the pan-European STOXX Europe 600 Index has climbed 3.00% recently, reflecting a broader optimism in European markets. As investors navigate these dynamic conditions, identifying promising small-cap stocks can be crucial; such stocks often exhibit strong fundamentals and growth potential that align with prevailing economic trends.

Genmab (CPSE:GMAB) is drawing fresh attention after announcing 23 abstracts for the 2026 ASCO and EHA meetings, largely centered on epcoritamab and other late stage oncology candidates in ongoing clinical trials. See our latest analysis for Genmab. Genmab's latest ASCO and EHA abstracts come after a mixed price pattern, with the share price up 3.62% over the past week but down 14.45% year to date. The 1 year total shareholder return of 23.17% contrasts with weaker 3 and 5 year total...

NKT (CPSE:NKT) is back in focus after reporting first quarter 2026 earnings, with sales of €864 million and net income of €61 million, alongside reaffirmed full year revenue guidance. See our latest analysis for NKT. At a share price of DKK1,106.0, NKT has delivered a 22.55% 30 day share price return and a 96.45% 1 year total shareholder return. If you are looking for other power and grid related opportunities after NKT's latest earnings, this could be a good moment to scan 35 power grid...

Carlsberg Baltics recently announced that long-serving regional head Rolandas Viršilas, who has led its Baltic operations for over 20 years, stepped down from his role on May 26, 2026, with Lukasz Chalaczkiewicz assuming leadership from May 27, 2026. This leadership transition brings in a new regional head with extensive FMCG experience across Central and Eastern Europe, potentially influencing how Carlsberg executes its growth and operational plans in Estonia, Latvia, and Lithuania. We’ll...

CHMP has issued a positive opinion for Novo Nordisk’s (CPSE:NOVO B) oral Wegovy pill, 25 mg semaglutide, for adult obesity in the EU. The committee also backed a higher dose Wegovy 7.2 mg single dose injection pen for weight management. Wegovy pill would be the first oral GLP 1 obesity treatment in the EU if the European Commission grants approval. The opinion is based on data from the OASIS and SELECT trials, which assessed weight loss and major adverse cardiovascular events. Launches are...

Demant (CPSE:DEMANT) has drawn investor attention after CEO Søren Nielsen warned that upcoming EU AI rules could create overlapping medical device regulations, potentially affecting approval timelines and competitiveness for European hearing healthcare companies. See our latest analysis for Demant. That warning comes as Demant’s share price has moved sharply higher in the short term, with a 1 month share price return of 20.47% and 3 month share price return of 38.33%. This contrasts with a 1...

FLSmidth (CPSE:FLS) stock has been drawing attention after a mixed pattern of returns, with a gain of 13% over the past week, 3% over the past month, but a 6% decline over the past 3 months. See our latest analysis for FLSmidth. With the share price at DKK516.0, FLSmidth has produced a strong 1 year total shareholder return of 45.17%, while the 90 day share price return is down 6.35%, suggesting recent momentum has cooled after a solid longer term run. If this kind of move has you thinking...

Last week's profit announcement from Hove A/S ( CPH:HOVE ) was underwhelming for investors, despite headline numbers...

Københavns Lufthavne (CPSE:KBHL) is back in focus after reporting first quarter 2026 results alongside reaffirmed full year guidance, tying stronger passenger traffic to higher revenue, earnings and a projected 7% revenue increase for 2026. See our latest analysis for Københavns Lufthavne. Against this backdrop, the stock’s 1 day share price return of 1.37% sits within a weaker recent patch. The 90 day share price return is down 8.39% and the 1 year total shareholder return is down 10.88%,...

Readers hoping to buy TORM plc ( CPH:TRMD A ) for its dividend will need to make their move shortly, as the stock is...

It's been a good week for TCM Group A/S ( CPH:TCM ) shareholders, because the company has just released its latest...

H. Lundbeck A/S' ( CPH:HLUN B ) recent earnings report didn't offer any surprises, with the shares unchanged over the...

Bavarian Nordic (CPSE:BAVA) received a major contract extension from the US government’s BARDA for its JYNNEOS smallpox vaccine. The extension secures remaining JYNNEOS doses and includes an additional US$97 million commitment for further vaccine supply. The agreement supports a shift to a freeze dried formulation designed for longer shelf life and stockpile use. The company has updated its 2026 revenue and business guidance following the new BARDA commitments. For investors looking at...

Djurslands Bank Q1 2026 Earnings Snapshot Djurslands Bank (CPSE:DJUR) has reported Q1 2026 revenue of DKK 172.1 million and net income of DKK 54.4 million, setting the tone for a new financial year after a period where trailing twelve month revenue stood at DKK 701.3 million and net income at DKK 247.8 million. The bank has seen quarterly revenue move between DKK 157.1 million and DKK 198.1 million over the past year, while net income has ranged from DKK 45.4 million to DKK 83.6 million. This...

Aktieselskabet Schouw (CPSE:SCHO) has called a special meeting to review the offering circular and indicative price range for the planned IPO of its fish feed subsidiary, BioMar Group A/S, on Nasdaq Copenhagen. See our latest analysis for Aktieselskabet Schouw. The special meeting comes after a solid run for the stock, with a 1 month share price return of 5.24% and a 1 year total shareholder return of 20.43%. This points to improving momentum despite a modest 3 month share price decline of...

Investors may be wondering whether Vestas Wind Systems, at a recent price of DKK194.60, still offers value or if most of the opportunity is already priced in. The stock has returned 1.9% over the last 7 days, 1.6% over the last 30 days, 8.9% year to date, and 92.8% over the past year. Returns over the past 3 and 5 years show declines of 1.8% and 17.5% respectively. Recent headlines around Vestas Wind Systems have focused on the company as a key listed player in the global wind sector. This...

We wouldn't blame TORM plc ( CPH:TRMD A ) shareholders if they were a little worried about the fact that Jacob...

Rockwool (CPSE:ROCK B) has been drawing attention after a mixed run in its stock performance, with the share price up over the past month but down over the past 3 months and year. See our latest analysis for Rockwool. At a share price of DKK194.8, Rockwool’s recent 1 month share price return of 2.47% contrasts with a 1 year total shareholder return that declined 34.22%. This suggests recent momentum is improving after a weaker period. If Rockwool’s recent moves have you thinking about where...

TCM Group (CPSE:TCM) opened 2026 with Q1 revenue of DKK362.4 million and basic EPS of DKK1.45, setting the tone for how investors will read the latest numbers against the stock’s current price of DKK71.8. The company has seen quarterly revenue move from DKK308.1 million in Q1 2025 to DKK362.4 million in Q1 2026, while basic EPS shifted from DKK1.16 to DKK1.45 over the same period. Trailing twelve month EPS stands at DKK7.83 on revenue of DKK1,333.5 million, which puts the focus squarely on...

Last week, you might have seen that Matas A/S ( CPH:MATAS ) released its annual result to the market. The early...

Scandinavian Tobacco Group (CPSE:STG) has opened Q1 2026 with a recent quarterly run rate of DKK2,343.3 million in revenue and basic EPS of DKK2.1, set against a trailing 12 month revenue base that has moved from DKK9,202.1 million to DKK9,035.7 million while TTM EPS has shifted from DKK11.45 to DKK8.50. Over the same window, trailing net income excluding extra items has gone from DKK939.7 million to DKK669.4 million. The latest release therefore lands in a context where margins and earnings...